Tralokinumab May be Beneficial for Atopic Dermatitis Treatment in Special Patient Populations
In a study of patients with atopic dermatitis, tralokinumab was effective and safe in elderly patients and those with severe comorbidities.
CDC COVID-19 Vaccine Bridge Access Program Ends 4 Months Earlier than Planned
The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.
Global Study Builds on Previous Research Linking Semaglutide & Suicide: Daily Dose
Your daily dose of the clinical news you may have missed.
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD
In a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose
Many Patients with Chronic Hand Eczema Report Having Corticosteroid Phobia, Shows New Research
In a study of patients with CHE, 75.5% of participants totally or almost agreed that topical corticosteroids cause damage to skin.
Updated mRNA COVID-19 Vaccines: Daily Dose
Moderna launches COVID booster campaign
The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.
The System Isn’t Working for Americans with Kidney Disease
Today, nearly 37 million Americans have chronic kidney disease (CKD), yet only about one percent of those Americans are even aware of their disease. And access to care is under threat.
Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction
ESC 2024: Findings from the FINEARTS-HF clinical trial provide the first definite evidence that an MRA can be beneficial in patients with HFmrEF/HFpEF.
Regular Aspirin Use for CRC Prevention Found to Benefit Unhealthy Adults Most: Daily Dose
FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose
Recreational Drug Users Face Triple the Risk of Repeat Major Adverse CV Events vs Non-Users
ESC 2024: Cannabis, opioid, and MDMA use were most strongly tied to cardiovascular event risk, according to a new study.
Geography May Matter in Dementia Diagnosis: Daily Dose
PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose
T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association
Type 2 diabetes and prediabetes were associated with accelerated brain aging, particularly among men and persons with poor cardiometabolic health, according to new research.
New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment
In a study of adolescents with obesity, symptoms of depression and eating disorders decreased over the course of a 52-week intensive behavioral intervention.
Global Disparities in Cancer Cases, Deaths Among Men: Daily Dose
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine / Image credit: ©M.Rode-Foto/AdobeStock")
